ONDSHIGH SIGNALFINANCIAL10-K

ONDS reported substantially deteriorated operating losses alongside meaningfully expanded R&D spending, indicating significant operational headwinds despite continued investment in development activities.

The company's operating performance has deteriorated substantially, with losses expanding considerably while R&D expenses grew meaningfully, suggesting either aggressive investment in new initiatives or operational challenges requiring increased spending to maintain competitiveness. The modest improvement in debt position provides some balance sheet relief, but the overall trajectory signals mounting operational pressure that investors should monitor closely.

Comparing 2026-03-30 vs 2025-03-12View on EDGAR →
FINANCIAL ANALYSIS

ONDS experienced a challenging financial period with operating losses expanding substantially from the prior year, driven partly by meaningfully higher R&D expenses that grew notably as the company appears to be investing aggressively in development activities. Operating cash outflows increased modestly while capital expenditures rose by approximately 24%, indicating continued operational cash burn alongside measured infrastructure investment. The company did reduce total debt by 55% to $300K, providing some balance sheet improvement, but the overall financial picture reflects mounting operational challenges requiring sustained investment spending.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
-68.7%
-$34.6M-$58.4M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

R&D Expense
P&L
+67.3%
$12.5M$20.9M

R&D investment increased 67.3% — signals commitment to future product development, though near-term margin impact.

Total Debt
Balance Sheet
-55%
$666K$300K

Debt reduced 55% — deleveraging strengthens balance sheet and reduces financial risk.

Capital Expenditure
Cash Flow
+24.3%
$1.6M$2.0M

Capex increased 24.3% — ongoing investment in capacity or infrastructure for future growth.

Operating Cash Flow
Cash Flow
-15.8%
-$33.5M-$38.7M

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

LANGUAGE CHANGES
NEW — 2026-03-30
PRIOR — 2025-03-12
ADDED
The aggregate market value of the registrant s common stock held by non-affiliates, computed by reference to the price at which the common stock was last sold on June 30, 2025, was approximately $ 392 million.
Market for Registrant s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 43 Item 6.
Management s Discussion and Analysis of Financial Condition and Results of Operations 43 Item 7A.
Changes in and Disagreements With Accountants on Accounting and Financial Disclosures 52 Item 9A.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 53 Item 13.
+7 more — sign up free →
REMOVED
For purposes of this computation, all officers, directors, and 10% beneficial owners of the registrant are deemed to be affiliates.
Such determination should not be deemed to be an admission that such officers, directors, or 10% beneficial owners are, in fact, affiliates of the registrant.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS From time to time we make statements concerning our expectations, beliefs, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are not historical facts.
Forward-looking statements may appear throughout this report, including without limitation, the following sections: Item 1 Business, Item 1A Risk Factors, and Item 7.
Management s Discussion and Analysis of Financial Condition and Results of Operations.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →